Glucotrack (Nasdaq:GCTK) may be bringing its continuous blood glucose monitor (CBGM) technology to automated insulin delivery ...

The CBGM is a long-term implantable device with no on-body external component. It is designed to provide three years of continuous, accurate blood glucose monitoring, offering a more convenient ...

The CBGM is a long-term implantable device with no on-body external component. It is designed to provide three years of continuous, accurate blood glucose monitoring, offering a more convenient and ...

(Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that ...

Testing in Diabetic Rats The researchers designed an implantable device containing the sensors within a microneedle, comparable in size to those used in continuous glucose monitors. This ...

Glucotrack’s Continuous Blood Glucose Monitor (CBGM) will provide real ... We are honored to join FORGETDIABETES to develop a fully implantable closed loop system for people living with diabetes.” ...

A new agreement with OneTwo Analytics AB will allow Glucotrack to leverage next-generation artificial intelligence and machine learning-based analytics to evaluate clinical study data from its continu ...

A brain implant has restored speech in a woman with severe paralysis, a breakthrough advance in enabling communication for people who have lost the ability to speak. At such a critical moment in US ...

The Company is currently developing a long-term implantable continuous blood glucose monitoring system for people living with diabetes. This news release contains forward-looking statements within the ...